retatrutide what is it Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Retatrutide FDA Approval Status 2026:
Description
Chronic central (intracerebroventricular) or peripheral (subcutaneous) infusion of GIP analogue in mice increased cFos neuronal activity in hypothalamic feeding center, resulting in reduced food intake and body weight
While neither drug is officially approved by the FDA for weight loss, they are frequently used off-label for this purpose
But here's what's important: muscle loss is not a direct effect of GLP-1 medications
In the same study, tirzepatide cut the risk of hospitalisation for heart failure or death from any cause by 58%
doi: 10.1136/bmj.l4898 [DOI] [PubMed] [Google Scholar] 35
